HTGC - Hercules Capital Inc Stock Price, Fair Value and News

21.43USD+0.30 (+1.42%)Market Closed

Market Summary

USD21.43+0.30

Market Closed

1.42%

HTGC Alerts

1 major insider buys and 1 major insider sales recently.

HTGC Stock Price

View Fullscreen

HTGC RSI Chart

HTGC Valuation

Market Cap

3.5B

Price/Earnings (Trailing)

10.41

Price/Sales (Trailing)

7.33

Price/Free Cashflow

-37.88

HTGC Price/Sales (Trailing)

HTGC Profitability

Return on Equity

17.7%

Return on Assets

9.03%

Free Cashflow Yield

-2.64%

HTGC Fundamentals

HTGC Revenue

Revenue (TTM)

474.0M

Rev. Growth (Yr)

15.9%

Rev. Growth (Qtr)

-7.52%

HTGC Earnings

Earnings (TTM)

333.9M

Earnings Growth (Yr)

-3.81%

Earnings Growth (Qtr)

-24.31%

Breaking Down HTGC Revenue

Last 7 days

1.2%

Last 30 days

6.4%

Last 90 days

12.4%

How does HTGC drawdown profile look like?

HTGC Financial Health

HTGC Investor Care

Shares Dilution (1Y)

13.87%

Diluted EPS (TTM)

2.21

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	474.0M	0	0	0
2023	356.4M	400.5M	433.1M	458.1M
2022	291.2M	301.3M	311.5M	321.7M
2021	0	0	284.1M	281.0M
2020	0	0	0	287.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies.

CEO	Mr. Scott Bluestein
WEBSITE	htgc.com
INDUSTRY	Asset Management
EMPLOYEES	100

Hercules Capital Inc Frequently Asked Questions

What is the ticker symbol for Hercules Capital Inc? What does HTGC stand for in stocks?

HTGC is the stock ticker symbol of Hercules Capital Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hercules Capital Inc (HTGC)?

As of Fri Jul 26 2024, market cap of Hercules Capital Inc is 3.48 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HTGC stock?

You can check HTGC's fair value in chart for subscribers.

Is Hercules Capital Inc a good stock to buy?

The fair value guage provides a quick view whether HTGC is over valued or under valued. Whether Hercules Capital Inc is cheap or expensive depends on the assumptions which impact Hercules Capital Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HTGC.

What is Hercules Capital Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, HTGC's PE ratio (Price to Earnings) is 10.41 and Price to Sales (PS) ratio is 7.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HTGC PE ratio will change depending on the future growth rate expectations of investors.